SCHEMBL24088075

SCHEMBL24088075

CN(C)S(=O)(=O)NC(=O)CSc1[nH]c(=O)cc(Cc2ccccc2)c1C#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ ALDH1A1 P00352 7/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HTT P42858 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ MAPT P10636 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.39
▸ TP53 P04637 1/20 0.37
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087892 0.89 LMNA (0.53) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL26847300 0.86 LMNA (0.58) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL24088076 0.84 LMNA (0.55) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL20340210 0.81 KDM4E (0.58) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL24087954 0.79 KDM4E (0.65) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL20350883 0.77 ALDH1A1 (0.47) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL24087893 0.77 RXFP1 (0.49) LMNAHSD17B10ALDH1A1KMT2AHPGD
SCHEMBL20351084 0.75 ALDH1A1 (0.45) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL20350809 0.74 KDM4E (0.55) LMNAHSD17B10ALOX15ALDH1A1KMT2A
SCHEMBL24087880 0.74 ALDH1A1 (0.42) LMNAHSD17B10ALOX15ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 LMNA 2315/4885HSD17B10 757/4885ALOX15 959/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 LMNA 2315/4885HSD17B10 757/4885ALOX15 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback